The coupling of FEN1 and DNA-PKcs deficiency resulted in dramatic replication fork collapse, genome instability and synthetic lethality in glioma cells, highlighting a promising strategy for glioma therapy, particularly for glioma cells harboring oncogene mutations. Here, PRKDC is linked to central nervous system cancer.